Verrica Pharmaceuticals Inc. Common Stock (VRCA) is a publicly traded Healthcare sector company. As of November 5, 2026, VRCA trades at $3.45 with a market cap of $56.52M and a P/E ratio of -2.43. VRCA moved -0.29% today. Year to date, VRCA is -60.88%; over the trailing twelve months it is +5.79%. Its 52-week range spans $3.20 to $9.82. Analyst consensus is strong buy with an average price target of $13.67. Rallies surfaces VRCA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for VRCA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $3.45 |
| Market Cap | $56.52M |
| P/E Ratio | -2.43 |
| EPS | $-1.75 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.82 |
| 52-Week Low | $3.20 |
| Volume | 443 |
| Avg Volume | 0 |
| Revenue (TTM) | $30.32M |
| Net Income | $-31.18M |
| Gross Margin | 0.00% |
4 analysts cover VRCA: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.67.